Safety and preliminary efficacy of LYS-GM101 gene therapy in patients with GM1 gangliosidosis: Results of a phase I/II open-label clinical trial
- Resource Type
- Abstract
- Source
- In
Molecular Genetics and Metabolism February 2024 141(2) - Subject
- Language
- ISSN
- 1096-7192